E-ISSN 2757-8062
Volume: 53 Issue: 1 Year: 2022

Quick Search




AMH and FSFI scores improved after recovery from COVID-19 pneumonia [Zeynep Kamil Med J]
Zeynep Kamil Med J. 2022; 53(1): 37-39 | DOI: 10.14744/zkmj.2021.80488

AMH and FSFI scores improved after recovery from COVID-19 pneumonia

Niyazi Tuğ1, Ceyhun Kılınç1, Pınar Eker2, Emre Yavuz1, Edip Emir1, Murat Yassa1, Pınar Birol1, Gaye Karagün Arslan1
1Department of Obstetrics and Gynecology, Şehit Prof. Dr. İlhan Varank Training and Research Hospital, İstanbul, Turkey
2Northern Clinics of İstanbul, Central Laboratory-2, İstanbul, Turkey

INTRODUCTION: The aim of this study was to investigate the effect of SARS-CoV-2 infection on female genitalia and sexual behavior.
METHODS: In this prospective cohort study in a COVID-19 pandemic clinic, women between 20 and 45 years of age with COVID-19 pneumonia but did not require intensive care were included. Serum anti-Müllerian hormone (AMH) measurements and female sexual function index (FSFI) scores were obtained during SARS-CoV-2 infection and 60–100 days after recovery.
RESULTS: Mean serum AMH concentrations at and after COVID-19 pneumonia were 2.29±1.84 and 2.92±2.46, respectively (p=0.017). FSFI scores after COVID-19 pneumonia were higher than those before the infection in all domains (p<0.05).
DISCUSSION AND CONCLUSION: SARS-CoV-2 infection seems to decrease AMH levels transiently in patients with pulmonary involvement, and recovery from the disease improves FSFI scores during the pandemics.

Keywords: AMH, COVID-19, FSFI, pneumonia, SARS-CoV-2.

Niyazi Tuğ, Ceyhun Kılınç, Pınar Eker, Emre Yavuz, Edip Emir, Murat Yassa, Pınar Birol, Gaye Karagün Arslan. AMH and FSFI scores improved after recovery from COVID-19 pneumonia. Zeynep Kamil Med J. 2022; 53(1): 37-39

Corresponding Author: Niyazi Tuğ, Türkiye
Manuscript Language: English
LookUs & Online Makale